Catherine Klersy to Tumor Necrosis Factor-alpha
This is a "connection" page, showing publications Catherine Klersy has written about Tumor Necrosis Factor-alpha.
Connection Strength
0.020
-
Factors influencing the choice of first- and second-line biologic therapy for the treatment of rheumatoid arthritis: real-life data from the Italian LORHEN Registry. Clin Rheumatol. 2017 Apr; 36(4):753-761.
Score: 0.020